- $1.47bn
- $731.61m
- $492.05m
- 92
- 82
- 38
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 156 | 206 | 358 | 454 | 492 |
Cost of Revenue | |||||
Gross Profit | 136 | 175 | 304 | 381 | 411 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 96.7 | 133 | 190 | 256 | 296 |
Operating Profit | 59.6 | 72.8 | 167 | 198 | 196 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 62 | 76.1 | 168 | 201 | 217 |
Provision for Income Taxes | |||||
Net Income After Taxes | 61.2 | 75 | 165 | 162 | 198 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 61.1 | 75 | 165 | 162 | 198 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 61.1 | 75 | 165 | 162 | 198 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.803 | 0.891 | 1.92 | 1.89 | 2.3 |